These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1589754)

  • 1. Biotech's second generation.
    Gibbons A
    Science; 1992 May; 256(5058):766-8. PubMed ID: 1589754
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech's twentieth birthday blues.
    Miska D
    Nat Rev Drug Discov; 2003 Mar; 2(3):231-3. PubMed ID: 12612649
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech's billion dollar breakthrough.
    Stipp D
    Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech's wonder ride.
    Rynecki D
    Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech's next big blowup?
    Stires D
    Fortune; 2002 Mar; 145(6):154. PubMed ID: 11913033
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech's perfect storm.
    Karberg S
    Cell; 2009 Aug; 138(3):413-5. PubMed ID: 19665960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Belgian biotech's clot-buster approved for aging eyes.
    Sheridan C
    Nat Biotechnol; 2012 Dec; 30(12):1158. PubMed ID: 23222770
    [No Abstract]   [Full Text] [Related]  

  • 8. Reading genes that spell health and disease.
    Landegren U
    Trends Biotechnol; 1996 Sep; 14(9):329-31. PubMed ID: 8818285
    [No Abstract]   [Full Text] [Related]  

  • 9. A blueprint for biotech's blues.
    Nat Biotechnol; 2009 Aug; 27(8):675. PubMed ID: 19668152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 11. Unleashing biotech's crouching tiger.
    Nat Biotechnol; 2018 May; 36(5):373. PubMed ID: 29734299
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech's gender gap.
    Littlehales C
    Nat Biotechnol; 2005 Sep; 23(9):1041-2. PubMed ID: 16222766
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech's wellspring-a survey of the health of the private sector in 2015.
    Huggett B
    Nat Biotechnol; 2016 Jun; 34(6):608-15. PubMed ID: 27281417
    [No Abstract]   [Full Text] [Related]  

  • 14. Indian biotech's bumpy road.
    Basu P
    Nature; 2007 Nov; 450(7169):580-1. PubMed ID: 18087777
    [No Abstract]   [Full Text] [Related]  

  • 15. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E
    Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech's uncertain present.
    Lancet; 1996 Jun; 347(9014):1497. PubMed ID: 8684093
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-mutation screening using PCR and ligation--principles and applications.
    Winn-Deen ES
    Trends Biotechnol; 1996 Apr; 14(4):112-4. PubMed ID: 8936430
    [No Abstract]   [Full Text] [Related]  

  • 18. Leveraging biotech's drug discovery expertise for neglected diseases.
    Lowell JE; Earl CD
    Nat Biotechnol; 2009 Apr; 27(4):323-9. PubMed ID: 19352364
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech's role in science education.
    Hassler S
    Biotechnology (N Y); 1994 Jul; 12(7):647. PubMed ID: 7764906
    [No Abstract]   [Full Text] [Related]  

  • 20. A very firm handshake: biotech's growing negotiating power.
    Thiel KA
    Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.